Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection

Journal of the College of Physicians and Surgeons Pakistan

Volumn 19, Issue 11, 2009, Pages 694-698

  Khan, Rustam ^a   Abid, Shahab ^a   Jafri, Wasim ^a   Awan, Safia ^a   Hamid, Saeed ^a   Shah, Hasnain ^a   Pervez, Shahid ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Cirrhosis; Infection; MELD score

Indexed keywords

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; CHILD TURCOTT PUGH SCORE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DEMOGRAPHY; DESCRIPTIVE RESEARCH; FEMALE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SHOCK; UREA NITROGEN BLOOD LEVEL;

ADULT; AGED; BILIRUBIN; BLOOD UREA NITROGEN; CREATININE; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROGNOSIS; RISK ASSESSMENT; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 73349116549     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Organ procurement and transplantation Network; final rule revision of comment period and effective dates - HRSA. Extension of comment period and delay of effective date for the organ procurement and transplantation network. Fed Regist 1998; 36:35847.
2. unos.org [Internet]. Virginia: Network for organ sharing; c2009. Availabale from: http//www.unos.org/resources/MeldPeldCalculator.asp?index=98
3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31:864-71. Comment in: Hepatology 2000; 32:881.
4. Kemmer N, Neff G, Kaiser T, Zacharias V, Thomas M, Tevar A, et al. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma. Liver Transpl 2006; 12:1519-22. Comment in: p. 1445-7.
5. Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75:193-9.
6. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology 2007; 45:789-96.
7. Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jimenez W, Arroyo V, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology 2005; 41:1282-9.
8. Perkins L, Jeffries M, Patel T. Utility of pre-operative scores for predicting morbidity after cholecystectomy in patients with cirrhosis. Clin Gastroenterol Hepatol 2004; 2:1123-8.
9. Yang YY, Lin HC. Bacterial infections in patients with cirrhosis. J Chin Med Assoc 2005; 68:447-51.
10. Christou L, Pappas G, Falagas ME. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol 2007; 102:1510-7. Epub 2007 May 17. Comment in: Am J Gastroenterol 2008; 103:248.
11. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoll F, et al. Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 33:41-8. Comment in: p. 9-12.
12. Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol 2005; 42:S85-92. Epub 2005 Jan 18.
13. Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, et al. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. Gastroenterol 2005; 129:1944-53.
14. Obstein KL, Campbell MS, Reddy KR, Yang YX. Association between model for end-stage liver disease and spontaneous bacterial peritonitis. Am J Gastroenterol 2007; 102:2732-6. Epub 2007 Aug 21.
15. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-8.
16. Caly WR, Strauss E. A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 1993; 18:353-8. Comment in: p. 271-2.
17. Sobel JD, Kaye D. Urinary tract infections. In: Mandell GL, Bennet JE, Dolin R, editors. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone; 1995. p. 662-90.
18. Akriviadis EA, Runyon BA. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology 1990; 98:127-33. Comment in: p. 230-6.
19. Ruiz-del-Arbol L, Urman J, Fernández J, González M, Navasa M, Monescillo A, et al. Systematic, renal and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003; 38:1210-8.
20. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 2001; 7:1730-54.
21. Valenti WM, Chiarello LA. Overview of hospital infection control and nosocomial infections: a practical approach to infectious diseases. Boston: Lippincott; 1986.
22. Hoffbauer FW, Rames ED, Meinert JK. Limitations and merits of a single serum sample analysis in differential diagnosis of jaundice. J Lab Clin Med 1949; 34:1259-78.
23. Sherlock S. Biochemical investigations in liver disease: some correlations with hepatic histology. J Pathol Bacteriol 1946; 58:523-8.
24. Harinasuta U, Chomet B, Ishak K, Zimmerman HJ. Steatonecrosis: mallory body type. Med (Baltimore) 1967; 46:141-62.
25. Kim WR, Wiesner RH, Therneau TM, Poterucha JJ, Porayko MKE, Vans RW, et al. Optimal timing of liver transplantation for primary biliary cirrhosis. Hepatology 1998; 28:33-8. Comment in: Hepatology 1999; 29:609-10.